COX-2 inhibitors: increased risk of CV events?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2001年 / 867卷 / 1期

关键词：

Celecoxib; Naproxen; Rofecoxib; Nabumetone; Adverse Event Reporting System;

D O I：

10.2165/00128415-200108670-00001

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] Proposed risk of CV events with COX-2 inhibitors debated
Reactions Weekly, 2002, 883 (1) : 6 - 7
[2] Mechanisms of COX-2 inhibitors a possible link to CV events?
Reactions Weekly, 2005, 1056 (1) : 5 - 5
[3] Risk of cardiovascular events associated with COX-2 inhibitors
不详
HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
[4] Risk of cardiovascular events associated with selective COX-2 inhibitors
Mukherjee, D
Nissen, SE
Topol, EJ
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
[5] Cardiovascular events and COX-2 inhibitors
Singh, G
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22): : 2810 - 2811
[6] COX-2 inhibitors: lower GI bleeding risk but population risk increased?
Reactions Weekly, 2004, 1002 (1) : 3 - 3
[7] Selective COX-2 inhibitors and risk of thromboembolic events regulatory aspects
Heim, Hans-Karl
Broich, Karl
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 423 - 432
[8] Why do COX-2 inhibitors increase risk of cardiovascular events?
Frankish, H
LANCET, 2002, 359 (9315): : 1410 - 1410
[9] COX-2 inhibitors and risks for cardiovascular events
Kazuki Takada
Arthritis Research & Therapy, 3 (1)
[10] COX-2 inhibitors and cardiovascular risk
Funk, Colin D.
FitzGerald, Garret A.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479

← 1 2 3 4 5 →